Vimarsana
Biggest News Aggregation in the World

Page 32 - Key Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Key Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Key Research Today - Breaking & Trending Today

Tandem Cell with Antimony Selenide Exceeds Single-Junction Efficiency - Vimarsana News

Tandem Cell with Antimony Selenide Exceeds Single-Junction Efficiency

An international group of researchers from the University of Science and Technology of China developed a proof-of-concept tandem solar cell tandem solar cell for the first time, by using antimony selenide for the bottom cell and a wide-bandgap organic-inorganic hybrid perovskite material for the top cell.

Source: azom.com
Pamrevlumab for Idiopathic Pulmonary Fibrosis - Vimarsana News

Pamrevlumab for Idiopathic Pulmonary Fibrosis

This randomized clinical trial compares the efficacy and safety of pamrevlumab vs placebo for patients with idiopathic pulmonary fibrosis.

Transforming CO2 into Sustainable Aviation Fuel - Vimarsana News

Transforming CO2 into Sustainable Aviation Fuel

A research group led by Professor Fei Wei and Chenxi Zhang at Tsinghua University has published a perspective study in the journal Carbon Future.

Revolutionizing Spectrometry with Ultra-Simplicity: Disrupting Conventional Designs through Novel Diffraction Computing - Vimarsana News

Revolutionizing Spectrometry with Ultra-Simplicity: Disrupting Conventional Designs through Novel Diffraction Computing

Miniaturizing spectrometers for compact and cost-effective mobile platforms is a significant challenge in current spectroscopy research.

The global distribution and the risk prediction of relapsing fever group Borrelia | Institute for Health Metrics and Evaluation - Vimarsana News

The global distribution and the risk prediction of relapsing fever group Borrelia | Institute for Health Metrics and Evaluation

We mapped the diversity, distribution, and potential infection risk of merging relapsing fever group Borrelia species.